Thought Leader, New Marketplace

Thomas W. Feeley, MD

Head of the Institute for Cancer Care Innovation
University of Texas MD Anderson Cancer Center


Thomas W. Feeley is the Helen Shafer Fly Distinguished Professor of Anesthesiology and Head of the Institute for Cancer Care Innovation at the University of Texas MD Anderson Cancer Center. He has a joint faculty appointment at the Harvard Business School where he is a Senior Fellow in the Institute for Strategy and Competitiveness. Dr. Feeley received both undergraduate and M.D. degrees from Boston University and trained in anesthesiology and critical care at Boston’s Beth Israel Hospital. He was a faculty member at Stanford University for 19 years practicing cardiovascular anesthesia and critical care. In 1997 he came to MD Anderson to create and lead the Division of Anesthesiology and Critical Care. He served 18 years as the head of that organization which grew to be the largest program of its kind devoted to cancer anesthesiology and critical care. He also served for 6 years as the Vice President of Medical Operations at the Cancer Center before creating the Institute for Cancer Care Innovation. His work with the Institute focuses on research to demonstrate and improve the value of cancer care delivery. Dr. Feeley recently served on the Institute of Medicine’s committee on Improving the Quality of Cancer Care: Addressing the Needs of an Aging Population that produced the report titled Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis that was released in September of 2013. Dr. Feeley was recently appointed by former Texas Governor Rick Perry to the Board of Directors of the Institute for Health Care Quality and Efficiency. At the Harvard Business School Dr. Feeley works in the Institute for Strategy and Competitiveness with Professor Michael Porter and Robert Kaplan on research and education projects related to value-based health care.

Care Redesign
Relentless Reinvention

How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures

The University of Texas MD Anderson Cancer Center used a streamlined methodology to arrive at measure sets for six disease sites; each set took just 1 to 2 months.

New Marketplace
New Risk, New Business Models

Making American Health Care Great Again, by Repealing and Replacing the ACA

Our nation has a great opportunity to accelerate value in health care by preserving the good in the ACA and addressing the bad.

New Marketplace
New Risk, New Business Models

Developing Bundled Reimbursement for Cancer Care

MD Anderson Cancer Center teamed with UnitedHealthcare to explore bundled payments for head and neck cancer.

New Marketplace
New Risk, New Business Models

Why Value in Health Care Is the Target

Fixing our health care system cannot be done simply by government fiat or by any party acting alone, but only with all stakeholders focusing in tandem on value for the patient.

Care Redesign 2016

The Value of ICU Care at the End of Life

How do physicians decide the right care as patients approach death? The answer must come from the patient.

Leadership

Why Would Someone Become a Doctor?

What the future holds for medicine as a profession.

New Marketplace 2015

What We’re Reading: Dying in the ICU – One Family’s Perspective

Compelling story about an ICU cancer death, told from the family’s point of view.

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now